hemodynamic effect of ondasterone in parturients undergoing cesarean sectio
Phase 4
Not yet recruiting
- Conditions
- SurgeryFertility-femaleAnaesthesia
- Registration Number
- PACTR202011750758363
- Lead Sponsor
- dilla university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 112
Inclusion Criteria
Age between 18-35 years(67)
ASA physical status class II
Exclusion Criteria
•Hypersensitivity to ondansetron
•History of Hypertensive disorders, anemia, Heart disease, diabetes, and placenta previa
•Patient receiving selective serotonin reuptake inhibitor or migraine medication
•Obesity (BMI =29-35 kg/m2) (69)
•Height <155 cm(70)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does ondansetron target to prevent spinal-induced hypotension in parturients?
How does ondansetron compare to ephedrine or phenylephrine in managing hypotension during cesarean delivery?
Are there specific biomarkers that predict parturient response to ondansetron for hypotension prevention?
What adverse events are associated with ondansetron use in spinal anesthesia for cesarean delivery?
What are the potential combination therapies with ondansetron for optimizing hemodynamic stability in parturients?